184 related articles for article (PubMed ID: 35705233)
1. Novel Biomarker of Collagen Degradation Can Identify Patients Affected With Both Axial Spondyloarthritis and Crohn Disease.
Nielsen SH; Stahly A; Regner EH; Bay-Jensen AC; Karsdal MA; Kuhn KA
J Rheumatol; 2022 Dec; 49(12):1335-1340. PubMed ID: 35705233
[TBL] [Abstract][Full Text] [Related]
2. Extracellular matrix protein turnover markers are associated with axial spondyloarthritis-a comparison with postpartum women and other non-axial spondyloarthritis controls with or without back pain.
Port H; Nielsen SH; Madsen SF; Bay-Jensen AC; Karsdal M; Seven S; Sørensen IJ; Morsel-Carlsen L; Østergaard M; Pedersen SJ
Arthritis Res Ther; 2022 Jun; 24(1):152. PubMed ID: 35739562
[TBL] [Abstract][Full Text] [Related]
3. Levels of extracellular matrix metabolites are associated with changes in Ankylosing Spondylitis Disease Activity Score and MRI inflammation scores in patients with axial spondyloarthritis during TNF inhibitor therapy.
Holm Nielsen S; Sun S; Bay-Jensen AC; Karsdal M; Sørensen IJ; Weber U; Loft AG; Kollerup G; Thamsborg G; Madsen OR; Møller J; Østergaard M; Pedersen SJ
Arthritis Res Ther; 2022 Dec; 24(1):279. PubMed ID: 36564778
[TBL] [Abstract][Full Text] [Related]
4. Identification of patient endotypes and adalimumab treatment responders in axial spondyloarthritis using blood-derived extracellular matrix biomarkers.
Port H; Christiansen F; Nielsen SH; Frederiksen P; Bay-Jensen AC; Karsdal MA; Seven S; Sørensen IJ; Loft AG; Madsen OR; Ostergaard M; Pedersen SJ
RMD Open; 2024 Jan; 10(1):. PubMed ID: 38199849
[TBL] [Abstract][Full Text] [Related]
5. Extracellular matrix turnover biomarkers reflect pharmacodynamic effects and treatment response of adalimumab in patients with axial spondyloarthritis-results from two randomized controlled trials.
Port H; Holm Nielsen S; Frederiksen P; Madsen SF; Bay-Jensen AC; Sørensen IJ; Jensen B; Loft AG; Madsen OR; Østergaard M; Pedersen SJ
Arthritis Res Ther; 2023 Aug; 25(1):157. PubMed ID: 37626399
[TBL] [Abstract][Full Text] [Related]
6. Procollagen I N-terminal peptide correlates with inflammation on sacroiliac joint magnetic resonance imaging in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis: A cross-sectional study.
Li X; Liang A; Chen Y; Lam NS; Long X; Xu X; Zhong S
Mod Rheumatol; 2022 Jul; 32(4):770-775. PubMed ID: 34897520
[TBL] [Abstract][Full Text] [Related]
7. Comparison of ankylosing spondylitis and non-radiographic axial spondyloarthritis in a multi-ethnic Asian population of Singapore.
Hong C; Kwan YH; Leung YY; Lui NL; Fong W
Int J Rheum Dis; 2019 Aug; 22(8):1506-1511. PubMed ID: 31090201
[TBL] [Abstract][Full Text] [Related]
8. Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis.
Hušáková M; Bay-Jensen AC; Forejtová Š; Zegzulková K; Tomčík M; Gregová M; Bubová K; Hořínková J; Gatterová J; Pavelka K; Siebuhr AS
Sci Rep; 2019 Aug; 9(1):11218. PubMed ID: 31375691
[TBL] [Abstract][Full Text] [Related]
9. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).
Kroon FP; van der Burg LR; Ramiro S; Landewé RB; Buchbinder R; Falzon L; van der Heijde D
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010952. PubMed ID: 26186173
[TBL] [Abstract][Full Text] [Related]
10. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
Malaviya AN; Kalyani A; Rawat R; Gogia SB
Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
[TBL] [Abstract][Full Text] [Related]
11. Discriminant validity, responsiveness and reliability of the arthritis-specific Work Productivity Survey assessing workplace and household productivity within and outside the home in patients with axial spondyloarthritis, including nonradiographic axial spondyloarthritis and ankylosing spondylitis.
Osterhaus JT; Purcaru O
Arthritis Res Ther; 2014 Aug; 16(4):R164. PubMed ID: 25099160
[TBL] [Abstract][Full Text] [Related]
12. Circulating mature granzyme B+ T cells distinguish Crohn's disease-associated axial spondyloarthritis from axial spondyloarthritis and Crohn's disease.
Lefferts AR; Regner EH; Stahly A; O'Rourke B; Gerich ME; Fennimore BP; Scott FI; Freeman AE; Jones K; Kuhn KA
Arthritis Res Ther; 2021 May; 23(1):147. PubMed ID: 34022940
[TBL] [Abstract][Full Text] [Related]
13. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
Kilic E; Kilic G; Akgul O; Ozgocmen S
Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
[TBL] [Abstract][Full Text] [Related]
14. Sex differences in axial spondyloarthritis: data from a Portuguese spondyloarthritis cohort.
Cunha RN; Vieira-Sousa E; Khmelinskii N; Ávila-Ribeiro P; Couto M; Seixas MI; Martins N; Bernardes M; Martins A; da Silva AB; Lourenço MH; Miguel C; Tavares V; Valente P; Costa J; Rovisco J; Aguiar R; Afreixo V; Barcelos A
ARP Rheumatol; 2022; 1(1):42-48. PubMed ID: 35633576
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of anti-Kaiso autoantibody in axial spondyloarthritis.
Feng X; Tong W; Li J; Xu Y; Zhu S; Xu W
Front Immunol; 2023; 14():1156350. PubMed ID: 37063878
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of active inflammation, chronic structural damage, and response to treatment of sacroiliitis in axial spondyloarthritis using the Spondyloarthritis research consortium of Canada scoring system.
Zhang Y; Guo Z; Zhan Y; Qu J; Lei X
BMC Musculoskelet Disord; 2022 Jul; 23(1):654. PubMed ID: 35804360
[TBL] [Abstract][Full Text] [Related]
17. Epicardial adipose tissue thickness and growth differentiation factor 15 in axial spondyloarthritis: A cross-sectional study.
Okçu M; Koçak FA; Şaş S; Güçlü K
Saudi Med J; 2022 Sep; 43(9):1020-1026. PubMed ID: 36104054
[TBL] [Abstract][Full Text] [Related]
18. Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis.
Sagard J; Olofsson T; Mogard E; Marsal J; Andréasson K; Geijer M; Kristensen LE; Lindqvist E; Wallman JK
Arthritis Res Ther; 2022 Feb; 24(1):42. PubMed ID: 35151357
[TBL] [Abstract][Full Text] [Related]
19. Relationship between monocytes to lymphocytes ratio and axial spondyloarthritis.
Huang Y; Deng W; Zheng S; Feng F; Huang Z; Huang Q; Guo X; Huang Z; Huang X; Pan X; Li T
Int Immunopharmacol; 2018 Apr; 57():43-46. PubMed ID: 29471252
[TBL] [Abstract][Full Text] [Related]
20. Tumor Necrosis Factor-α Inhibition in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Treatment Response, Drug Survival, and Patient Outcome.
Corli J; Flipo RM; Philippe P; Bera-Louville A; Béhal H; Wibaux C; Paccou J
J Rheumatol; 2015 Dec; 42(12):2376-82. PubMed ID: 26568593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
